J

2020 Updates on Insulin Therapy: What Are the Current ADA Standards of Care?

By John Tayek 3 Videos
0 views
November 25, 2020
Comments 2
Login to view comments. Click here to Login

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

AUTOPLAY
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
19:15
Omnipod®

Omnipod 5® Learning Bytes Presentation: Unusual Suspects for AID

Feat. D. Desalvo
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
17:21
Ilene Fennoy

Obesity and Diabetes in Children

61:49
Obafemi Awolowo University

Management of Heart Failure

Feat. O. A. Akinyele
23:35
Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
08:46
Robert Busch

FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
26:49
Diana Isaacs

Tirzepatide Updates

26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen